Skip to content

Clinical Outcomes With a New Monofocal IOL Enhanced for Intermediate Vision

Clinical Outcomes With a New Monofocal Intraocular Lens Enhanced for Intermediate Vision

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04904887
Enrollment
40
Registered
2021-05-27
Start date
2020-11-01
Completion date
2021-10-30
Last updated
2021-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia

Brief summary

phacoemulsification with insertion of EYHANCE IOL to improve near and intermediate vision

Detailed description

insertion of new intraocular lens enhanced for intermediate vision

Interventions

PROCEDUREphacoemulsification

phacoemulsification with implantation of EYEHANCE IOL

Sponsors

Dar Al Shifa Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

patients undergoing cataract surgery are managed with phacoemulsification and insertion of Eyehance intraocular lens in order to improve their intermediate vision.

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* normal ocular examination apart from cataract.

Exclusion criteria

* previous ocular surgery. * ocular pathology or corneal abnormalities. * endothelial cell count below 2000 cells/mm2. * corneal astigmatism greater than 1.0 diopter (D) measured with Scheimpflug tomography (Sirius, CSO, Italy).

Design outcomes

Primary

MeasureTime frameDescription
intermediate vision assessment6 months postoperativelyStandardized logarithm of the minimum angle of resolution (logMAR) charts were used for visual acuity measurement at 80 cm .
near vision assessment6 months postoperativelyStandardized logarithm of the minimum angle of resolution (logMAR) charts were used for visual acuity measurement at 40 cm.

Secondary

MeasureTime frameDescription
defocus curve6 months postoperativelyThe curve was obtained while the patient wearing his distance correction to provide the best distance visual acuity in both eyes. The test was performed under photopic conditions (85 candelas/m2) using ETDRS charts at a distance of 4m with the introduction of defocusing lenses from +1.00 D to -4.00 D in 0.50 D steps.

Countries

Kuwait

Contacts

Primary ContactMagda Torky
magda_turkey@yahoo.com0096594492487

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026